Yuyu Pharma, Inc. (KRX:000220)
4,680.00
-30.00 (-0.64%)
At close: Jun 5, 2025, 3:30 PM KST
Yuyu Pharma Revenue
Yuyu Pharma had revenue of 32.91B KRW in the quarter ending March 31, 2025, a decrease of -1.49%. This brings the company's revenue in the last twelve months to 132.65B, down -2.69% year-over-year. In the year 2024, Yuyu Pharma had annual revenue of 133.15B, down -2.96%.
Revenue (ttm)
132.65B
Revenue Growth
-2.69%
P/S Ratio
0.57
Revenue / Employee
502.46M
Employees
264
Market Cap
75.73B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 133.15B | -4.06B | -2.96% |
Dec 31, 2023 | 137.21B | -1.67B | -1.20% |
Dec 31, 2022 | 138.88B | 23.23B | 20.08% |
Dec 31, 2021 | 115.66B | 17.54B | 17.87% |
Dec 31, 2020 | 98.12B | 7.24B | 7.97% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
LigaChem Biosciences | 146.42B |